Impact of COVID-19 pandemic on hospital onset bloodstream infections (HOBSI) at a large health system

Baker MA, Sands KE, Huang SS. The impact of COVID-19 on health care-associated infections. Clin Infect Dis, in press. DeVoe C, Segal MR, Wang L. Increased rates of secondary bacterial infections, including enterococcus bacteremia, in patients hospitalized with COVID-19. Infect Control Hosp Epidemiol, in press. Patel PR, Weiner-Lastinger LM, Dudeck MA. Impact of COVID-19 pandemic on central-line-associated bloodstream infections during the early months of 2020, National Health Care Safety Network. Infect Control Hosp Epidemiol, in press. Sloot R, Nsonwu O, Chudasama D. Rising rates of hospital-onset Klebsiella spp. and Pseudomonas aeruginosa bacteraemia in NHS acute trusts in England: a review of National Surveillance Data, August 2020 to February 2021. J Hosp Infect, in press. Weiner-Lastinger, 2022, The impact of coronavirus disease 2019 (COVID-19) on health care-associated infections in 2020: a summary of data reported to the National Health Care Safety Network, Infect Control Hosp Epidemiol, 43, 12, 10.1017/ice.2021.362 Wisplinghoff, 2004, Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clin Infect Dis, 39, 309, 10.1086/421946 Fakih, 2017, Introducing hospital onset bloodstream infection (HOBSI) as a tool to evaluate infection prevention: assessment of 51 US hospitals, Open Forum Infect Dis, 4, S181, 10.1093/ofid/ofx163.333 Sturm, 2020, Is hospital-onset bloodstream infection (HOBSI) a useful measure to evaluate infection prevention progress?, Infect Control Hosp Epidemiol, 41, s307, 10.1017/ice.2020.894 Centers for Disease Control and Prevention. National Health Care Safety Network (NHSN) Patient Safety Component Manual. Multidrug-Resistant Organism & Clostridium difficile Infection (MDRO/CDI) Module. Available at: http://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. Accessed July 1, 2021. Friedman, 2002, Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections, Ann Intern Med, 137, 791, 10.7326/0003-4819-137-10-200211190-00007 Shorr, 2006, Health care-associated bloodstream infection: a distinct entity? Insights from a large U.S. database, Crit Care Med, 34, 2588, 10.1097/01.CCM.0000239121.09533.09 Grasselli, 2021, Hospital-acquired infections in critically Ill patients with COVID-19, Chest, 160, 454, 10.1016/j.chest.2021.04.002 COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at: https://www.covid19treatmentguidelines.nih.gov. Accessed September 25, 2021. Fakih, 2021, COVID-19 hospital prevalence as a risk factor for mortality: an observational study of a multistate cohort of 62 hospitals, BMJ Qual Saf Fakih, 2022, Coronavirus disease 2019 (COVID-19) pandemic, central-line–associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts, Infect Control Hosp Epidemiol, 43, 26, 10.1017/ice.2021.70 Centers for Medicare & Medicaid Services. Hospital-Acquired Conditions. Available at: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalAcqCond/Hospital-Acquired_Conditions.html. Accessed October 4, 2021. Salmasian, 2021, Rethinking standardised infection rates and risk adjustment in the COVID-19 era, BMJ Qual Saf, 30, 588, 10.1136/bmjqs-2020-012074 Department of Health & Human Services. Centers for Medicare & Medicaid Services. Programs, Clinical Laboratory Improvement Amendments (CLIA), and Patient Protection and Affordable Care Act; Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency. Available at: https://www.cms.gov/files/document/covid-ifc-3-8-25-20.pdf. Accessed October 4, 2021. Fakih, 2018, Hospital-onset staphylococcus aureus bacteremia is a better measure than MRSA bacteremia for assessing infection prevention: evaluation of 50 US Hospitals, Infect Control Hosp Epidemiol, 39, 476, 10.1017/ice.2018.13